Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors

Immune checkpoint blockade reaches remarkable clinical responses. However, even in the most favorable cases, half of these patients do not benefit from these therapies in the long term. It is hypothesized that the activation of host immunity by co‐delivering peptide antigens, adjuvants, and regulato...

Descripción completa

Detalles Bibliográficos
Autores principales: Matos, Ana I., Peres, Carina, Carreira, Barbara, Moura, Liane I. F., Acúrcio, Rita C., Vogel, Theresa, Wegener, Erik, Ribeiro, Filipa, Afonso, Marta B., Santos, Fábio M. F., Martínez‐Barriocanal, Águeda, Arango, Diego, Viana, Ana S., Góis, Pedro M. P., Silva, Liana C., Rodrigues, Cecília M. P., Graca, Luis, Jordan, Rainer, Satchi‐Fainaro, Ronit, Florindo, Helena F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477894/
https://www.ncbi.nlm.nih.gov/pubmed/37434063
http://dx.doi.org/10.1002/advs.202300299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477894/
https://www.ncbi.nlm.nih.gov/pubmed/37434063
http://dx.doi.org/10.1002/advs.202300299

Ejemplares similares